Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_assertion type Assertion NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_head.
- NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_assertion wasGeneratedBy ECO_0000203 NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_provenance.
- NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_assertion wasDerivedFrom befree-20140225 NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_provenance.
- NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_assertion SIO_000772 20565290 NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_provenance.
- NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_assertion evidence source_evidence_literature NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_provenance.
- NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_assertion description "[However, it is not clear whether type I interferon receptor-1 (IFNAR-1) variations continuously exert their effects to influence the final outcomes following HBV chronicity, including acute-on-chronic hepatitis B liver failure (ACLF-HBV), chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854819.RAbz_r_53Y_Gwd3Sza6s2q1cZz-B8JCfOyvXfHVXBrWZk130_provenance.